首页> 外文期刊>Internal medicine. >Treatment of a Serotype-1 Hepatitis C Virus Infection Using Interferon-Beta in a Patient with a High RNA Titer Who Had Been Receiving Long-Term Hemodialysis Therapy
【24h】

Treatment of a Serotype-1 Hepatitis C Virus Infection Using Interferon-Beta in a Patient with a High RNA Titer Who Had Been Receiving Long-Term Hemodialysis Therapy

机译:用高RNA滴度接受长期血液透析治疗的患者干扰素 - β的血清型-1丙型肝炎病毒感染治疗血清型-1丙型肝炎病毒感染

获取原文
           

摘要

A serotype-1 hepatitis C virus (HCV) infection in a 67-year-old hemodialysis patient was treated using interferon (IFN)-beta. Although the patient had a high RNA titer (5.1 log IU/mL) and had been receiving long-term hemodialysis therapy (30 years), the initial 4-week IFN-beta administration enabled a rapid virological response without any major adverse effects. However, the final outcome after 24 weeks of IFN beta treatment was classified as unchanged based on the criteria of the Conference on Intractable Hepatitis. Here, we describe our experience treating HCV infection using IFN-beta and discuss the indications for such therapy.
机译:使用干扰素(IFN)-beta治疗67岁的血液透析患者中​​的血清型-1丙型肝炎病毒(HCV)感染。虽然患者具有高RNA滴度(5.1 log Iu / ml),并且已接受长期血液透析治疗(30年),但最初的4周IFN-Beta施用使得一种快速的病毒学反应,没有任何重大的不良反应。然而,在IFNβ治疗24周后的最终结果是根据难治性肝炎会议的标准归类为不变的。在这里,我们描述了使用IFN-β治疗HCV感染的经验,并讨论此类疗法的适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号